Hikma Pharmaceuticals (HIK)

Sector:

Pharma and Biotech

Index:

FTSE 100

1,636.00p
   
  • Change Today:
      9.00p
  • 52 Week High: 2,340.00
  • 52 Week Low: 1,607.00
  • Currency: UK Pounds
  • Shares Issued: 221.89m
  • Volume: 783,916
  • Market Cap: £3,630.06m
  • RiskGrade: 125
  • Beta: 0.00

Hikma surges as investors welcome medium-term guidance

By Michele Maatouk

Date: Thursday 15 May 2025

LONDON (ShareCast) - (Sharecast News) - Shares in Hikma Pharmaceuticals surged on Thursday as investors welcomed new medium-term guidance from the company.
Alongside a sell-side analysts and investors even at its manufacturing and R&D facility in Columbus, Ohio, the pharmaceuticals group said that for group revenue, it expects a three-year compound annual growth rate of 6% to 8% between 2024 and 2027.

For operating profit, it expects a three-year compound annual growth rate of 7% to 9%.

In addition, Hikma said introduced a five-year target for group revenue to reach $5bn by 2030.

At 1235 BST, the shares were up 8.1% at 2,098p.

Email this article to a friend

or share it with one of these popular networks:


Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: RiskGrade figures are provided by RiskMetrics.

 

HIK Market Data

Currency UK Pounds
Share Price 1,636.00p
Change Today 9.00p
% Change 0.55 %
52 Week High 2,340.00
52 Week Low 1,607.00
Volume 783,916
Shares Issued 221.89m
Market Cap £3,630.06m
Beta 0.00
RiskGrade 125

HIK Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
74.3% below the market average74.3% below the market average74.3% below the market average74.3% below the market average74.3% below the market average
31.71% above the sector average31.71% above the sector average31.71% above the sector average31.71% above the sector average31.71% above the sector average
Price Trend
51.95% below the market average51.95% below the market average51.95% below the market average51.95% below the market average51.95% below the market average
13.64% above the sector average13.64% above the sector average13.64% above the sector average13.64% above the sector average13.64% above the sector average
Income
38.55% above the market average38.55% above the market average38.55% above the market average38.55% above the market average38.55% above the market average
100.00% above the sector average100.00% above the sector average100.00% above the sector average100.00% above the sector average100.00% above the sector average
Growth
42.16% above the market average42.16% above the market average42.16% above the market average42.16% above the market average42.16% above the market average
3.45% above the sector average3.45% above the sector average3.45% above the sector average3.45% above the sector average3.45% above the sector average

What The Brokers Say

Strong Buy 6
Buy 3
Neutral 3
Sell 0
Strong Sell 0
Total 12
buy
Broker recommendations should not be taken as investment advice, and are provided by the authorised brokers listed on this page.

HIK Dividends

  Latest Previous
  Interim Final
Ex-Div 14-Aug-25 20-Mar-25
Paid 18-Sep-25 01-May-25
Amount 36.00¢ 48.00¢

Trades for 18-Sep-2025

Time Volume / Share Price
17:29 1,344 @ 1,631.17p
16:47 21,323 @ 1,630.28p
16:35 4,576 @ 1,636.00p
16:35 321,305 @ 1,636.00p
16:35 37 @ 1,636.00p

HIK Key Personnel

CEO Riad Mishlawi

Top of Page